How to Choose a Stem Cell Clinic Abroad: A 12-Point Checklist for International Patients (2026)

Stem cell therapy is regulated at the national level. In Turkey, the relevant authority is the Ministry of Health (Sağlık Bakanlığı). In other jurisdictions it may be the Cayman Islands government, COFEPRIS in Mexico, INVIMA in Colombia, or the relevant European competent authority.

Ask the clinic to name the specific authority that licenses their facility and the license type. A generic statement that a clinic is 'fully accredited' without a named issuer is not evidence of licensing.

There is a meaningful difference between a clinic that infuses cells supplied by a third party and a clinic that processes its own cells in an on-site or affiliated GMP-compliant laboratory. Both can be legitimate, but the supply chain should be transparent.

Ask: which laboratory processes the cells, where is it located, and is it GMP-compliant? Is it audited by a national authority? You should receive a clear, named answer.

'Umbilical cord-derived MSCs' is a broad category. The clinically meaningful detail is the specific tissue — Wharton's Jelly, umbilical cord blood, or perivascular tissue — and the donor screening protocol applied.

Reputable clinics use ethically donated umbilical cords from full-term scheduled C-sections, with consenting donors screened for infectious disease (HIV, HBV, HCV, syphilis, CMV, HTLV) per international standards. You should be told this in writing.

A meaningful dose disclosure includes the total number of viable cells delivered, the viability percentage (typically ≥85% post-thaw), and the route of administration (IV, intrathecal, intra-articular).

Vague language such as 'millions of cells' or 'maximum dose' without numbers is a warning sign. Clinics that publish dose ranges in writing tend to deliver consistent dose ranges in practice.

A Certificate of Analysis is the lab's written record for a specific batch: total viable cell count, viability, sterility, mycoplasma, endotoxin, and surface-marker phenotype (typically CD73+, CD90+, CD105+ / CD34−, CD45−, HLA-DR−).

Ask to see a sample CoA before booking and to receive the CoA for your own batch before infusion. A clinic that cannot produce this document on request cannot prove the identity, potency, or sterility of what is being infused.

The clinic should publish the name, photo, and credentials of the physician who will lead your treatment — not just a generic 'medical team.' Specialty board status, hospital affiliations, and years of experience should be checkable against public registries (e.g., the Turkish Medical Association directory).

If the website lists only first names, stock photos, or 'a team of leading experts' without verifiable detail, that is a meaningful gap.

Reputable international clinics publish either a fixed price or a clearly bounded price range for each program, and tell you in writing what is and is not included — typically: lab fees, infusion, hotel coordination, airport transfers, and follow-up.

Beware pricing that is intentionally withheld until a sales call, or that jumps materially during the consultation. A program that 'starts at' an attractive figure but actually delivers at 2–3× that price after add-ons is not transparent pricing.

Outcomes improve when patients are followed at 30, 60, 90, 180 and 365 days using condition-specific scales (WOMAC for knee OA, EDSS for MS, ATEC for autism, DAS28 for rheumatoid arthritis). Ask what the follow-up protocol looks like in writing.

If the answer is essentially 'message us if you have any issues,' there is no follow-up program — only an after-sales channel.

No legitimate clinic can ethically promise a cure, a percentage improvement guarantee, or a refund-if-it-doesn't-work clause for a biological therapy. Outcome language should be probabilistic, conservative, and grounded in published evidence.

If a clinic's marketing reads more like a sales page than a medical document — testimonials front and center, no risk language, no peer-reviewed citations — that is a structural warning, regardless of price.

Look for clinics that cite specific PubMed IDs or ClinicalTrials.gov NCT numbers for the indications they treat. The honest framing is that umbilical-cord MSCs have a growing peer-reviewed evidence base for several conditions — and remain investigational for others.

A clinic that quietly drops citations into its content and labels indications honestly is treating you like a partner in a medical decision. A clinic that promises certainty is treating you like a buyer.

A program designed around the therapy looks different from a program designed around an itinerary. Expect a brief, low-activity infusion day, a 24–48 hour observation window, and written post-procedure instructions covering anti-inflammatory medication avoidance (especially NSAIDs), alcohol restriction, hydration, and activity pacing.

If the clinic packages excursions before observation periods are complete, or pushes alcohol-included 'wellness retreats' around infusion, the patient is not the priority.

The strongest signal that a clinic is reputable is its willingness to decline patients who are not good candidates — late-stage organ failure, active malignancy, certain autoimmune flares, or patients whose primary issue would be better served by surgical or pharmacological intervention.

Ask: 'In what cases would you turn down a patient who wants to book?' A clinic that has a real, specific answer is doing the medicine. A clinic that accepts everyone is doing the sale.

TurkeyStemcell operates a Turkish Ministry of Health-licensed program with Wharton's Jelly MSC therapy processed in a GMP-compliant Istanbul laboratory. Every batch ships with a written Certificate of Analysis, and patients receive their own CoA before infusion.

Treating physicians are named and credentialed. Pricing is published as a bounded range for each program. Follow-up is structured at 30/60/90/180/365 days using validated outcome scales. We publish PubMed and ClinicalTrials.gov citations for every condition we treat, and we decline candidates for whom MSC therapy is not the appropriate next step.

Compare this checklist against any clinic you are considering — including ours. Transparency should not be a competitive differentiator. It should be the floor.